Diabetic Retinopathy Market to Reach $13.53B by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Diabetic Retinopathy Market Compare Between 2026 And 2030?
The market for diabetic retinopathy has seen robust expansion recently. Projections indicate it will expand from $9.26 billion in 2025 to $9.97 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this growth is linked to factors such as a rise in diabetes prevalence, delayed identification of retinal damage, restricted access to screening, an increase in cases of vision impairment, and reliance on eye care provided in hospitals.
The diabetic retinopathy market is projected to experience substantial expansion over the upcoming years. This market is set to reach $13.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Key factors contributing to this anticipated growth include the development of AI-assisted screening tools, the establishment of more ophthalmology clinics, increased uptake of anti-VEGF therapy, a heightened emphasis on preventive eye care, and an expanding elderly diabetic demographic. Prominent trends during this forecast period are expected to encompass the growing implementation of retinal screening programs, wider application of anti-VEGF therapies, enhanced early detection and monitoring capabilities, increasing integration of AI-based retinal imaging, and a greater focus on preserving vision.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report
Which Strong Drivers Are Impacting The Diabetic Retinopathy Market Growth?
The increasing incidence of diabetes is projected to drive expansion within the diabetic retinopathy market in the coming period. Diabetes is defined as a chronic metabolic condition characterized by elevated blood glucose levels. This rise in diabetes prevalence primarily stems from factors like being overweight, obesity, genetic predispositions, and lack of physical activity. Individuals with diabetes experience excessive blood sugar, which can harm the retina – the part of the eye responsible for light detection and transmitting signals to the brain via a nerve at the eye’s rear. As an illustration, in March 2024, data from the Office for Health Improvement and Disparities, a UK government body, indicated that between March 2022 and March 2023, the proportion of people with type 1 diabetes who received all eight suggested care processes saw a 22% increase. Simultaneously, for type 2 diabetes, this figure went up by 21%. Furthermore, the percentage of individuals achieving target HbA1c levels reached an unprecedented 37.9%, marking the highest figure ever documented by the National Diabetes Audit. Consequently, the expanding prevalence of diabetes is propelling the growth of the diabetic retinopathy market.
Which Segment Classifications Are Used In The Diabetic Retinopathy Market Segment Analysis?
The diabetic retinopathy market covered in this report is segmented –
1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy
2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment
2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR
Which Trends Are Contributing To Changes In The Diabetic Retinopathy Market?
Leading companies in the diabetic retinopathy market are concentrating on strategic partnerships to enhance their market profitability. Collaborations in diabetic retinopathy encompass joint initiatives among various entities like healthcare providers, researchers, pharmaceutical firms, and advocacy groups, all aimed at confronting the complexities linked with the condition. For example, in October 2023, AEYE Health, a US-based firm offering AI-driven diagnostics for retinal imaging, teamed up with Topcon Screen, a Japan-based platform for diabetic screening. The partnership’s purpose is to offer artificial intelligence-based point-of-care screening for diabetic retinopathy, guaranteeing quick and accurate results, which allows primary care clinicians to perform these screenings directly in their clinics. This strategy intends to lessen non-compliance rates and resolve care deficiencies related to diabetic retinopathy screening by providing immediate, precise assessments right at the point of care.
Which Firms Are Contributing To The Diabetic Retinopathy Market Ecosystem?
Major companies operating in the diabetic retinopathy market are Pfizer Inc., F‑Hoffmann‑La Roche Ltd., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Allergan plc., Genentech Inc., Santen Pharmaceutical Co Ltd., Carl Zeiss Meditec AG, Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co Ltd., IRIDEX Corporation, Alimera Science Inc., Oxurion NV, EyePoint Pharmaceuticals, Opthea Limited, KalVista Pharmaceuticals Inc., Regenxbio Inc., Kodiak Sciences Inc., Oculis, Verseon International Corporation, Clearside Biomedical Inc.
Get The Full Diabetic Retinopathy Market Report:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report
Where Is The Diabetic Retinopathy Market Most Concentrated Geographically?
North America was the largest region in the diabetic retinopathy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Diabetic Retinopathy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report
Browse Through More Reports Similar to the Global Diabetic Retinopathy Market 2026, By The Business Research Company
Diabetic Neuropathy Market Report 2026
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
Non Proliferative Diabetic Retinopathy Market Report 2026
Proliferative Diabetic Retinopathy Pdr Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
